Green Market Report…
Cannabis attorney David Feldman has formed a new law firm, Feldman Legal Advisors, PLLC. Feldman, who has focused on cannabis and psychedelics since 2013 and recently helped build and lead the 60+ attorney cannabis industry group at an AmLaw100 firm, will focus the new firm’s efforts on business and transactional matters in the industry. The CEO and Co-Founder of Skip Intro Advisors, LLC, a cannabis and psychedelics-focused consulting firm, Feldman said he believes the combination of legal and advisory services will offer a “one stop shop” for entrepreneurs, investment banks and investors in the space.
“I’ve had a very blessed career. I am always happiest on the cutting edge, whether in helping bring IPO alternatives into legitimacy and transparency, or over the last decade bringing cannabis and psychedelics into the mainstream. I’m so lucky to have gathered a wonderful group of talented friends who now will be colleagues at Feldman Legal Advisors,” said Feldman.
In addition to Feldman, the initial legal team will include Gretchen Temeles, Ph.D., an intellectual property attorney and scientist who will focus on patent and licensing issues in the cannabis and psychedelics space, and associate Melissa Greenberg, an experienced attorney focused on cannabis and wellness (she is also a certified yoga instructor), who joins from cannabis-focused law firm Hiller PC. Temeles and Greenberg will also offer non-legal advisory services at Skip Intro. Feldman said he plans to add additional specialties relevant to their cannabis and psychedelic clients to offer a comprehensive suite of services.
In 2019, Feldman launched Skip Intro Advisors, LLC to assist growing businesses in the cannabis and psychedelics space as they reach key inflection points. Skip Intro has a strong team of successful and experienced professionals both from within and outside the cannabis industry focused on strategy, finance and M&A, branding and marketing, technology and real estate. The firm, whose slogan is “Fast Forward to Growth,” also offers assistance with cannabis licensing applications. In a recent win, in May 2021 the firm negotiated the sale of Keystone Canna Remedies, a 3-dispensary group in Pennsylvania, to multistate operator TerrAscend Corp. (OTC: TRSSF) at a $70 million enterprise value. The firm is currently active in engagements relating to equipment and media businesses in the cannabis space, as well as assignments for psychedelics companies planning a go-public strategy.
”We offer personalized service at a much lower cost than the large law and consulting firms, lower even than many boutiques. For clients to know that we can find and negotiate business transactions on their behalf, then continue to assist with the legal work, provides simplicity, efficiency, predictability and cost-saving to the process. We are excited to add this integrated law practice to the growing success we are humbled to have achieved at Skip Intro,” added Feldman.
Feldman, who has published four books on finance and entrepreneurship, came to prominence in the 2000’s as a leading attorney in alternatives to traditional IPOs such as reverse mergers and direct listings. Starting in 2010, he worked with the SEC in implementing regulations regarding Regulation A+, a simplified and streamlined IPO created under the JOBS Act. Feldman is credited with coining the term “Regulation A+” now widely utilized to refer to the new technique and led the first Regulation A+ IPO onto the Nasdaq in 2017. Since 2013, he has worked on complex business transactions in the cannabis and psychedelics space, earning numerous accolades. These include top recognition from the global legal guide Chambers & Partners, being named a “Cannabis Law Trailblazer” by the National Law Journal and a top lawyer in the cannabis industry by Business Insider. He has also been listed in the Top 200 Cannabis Lawyers published by Cannabis Law Digest for the last two years.